ST2 as checkpoint target for colorectal cancer immunotherapy

Overview of attention for article published in JCI Insight, May 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 9 news outlets
blogs: 2 blogs

twitter: 12 X users
facebook: 1 Facebook page

Readers on

mendeley: 49 Mendeley

So far, Altmetric has seen 12 X posts from 12 X users, with an upper bound of 116,674 followers.

Der IL-33 Rezeptor ST2 ist ein neuer potentieller Angriffspunkt der #Immuncheckpoint- Inhibitor-Therapie beim kolorektalen Karzinom. 👉 https://t.co/FXZOKOCbMk #oncology #immunology #darmkrebs #CRC

RT @jclinicalinvest: In JCI Insight: ST2 as checkpoint target for colorectal cancer immunotherapy https://t.co/pZN2hjXh2F @sophpacz @IUMedS…

RT @DrEzraCohen: IL33-ST2 interruption may hold promise in colorectal cancer immunotherapy. https://t.co/pR1eMFGJW3

IL33-ST2 interruption may hold promise in colorectal cancer immunotherapy. https://t.co/pR1eMFGJW3

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 8 additional X posts.